Levetiracetam
Product Images NDC 70518-0554

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 70518-0554). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a description of LevETIRAcetam, a 500 mg tablet with a quantity of 30 tablets. The medication is available by prescription only and has a NDC number of 70518-0554-00. The manufacturer is Camber Pharma, Inc, located in Piscataway, NJ. The package insert provides directions for use, and it should be stored at 20-25°C (58-77°F). The medication is packaged by RemedyRepack Inc. in Indiana, PA.*

FDA Label Image

Levetiracetamtabletsfigure1

This is a statistical report on the percentage of patients in a study group, broken down into different categories ranging from 2% to 40%. The study involved two treatment groups, one given a placebo and the other administered Levetiracetam at different dosages. The sample size for each group is provided (N=95 for the placebo group and N=101 for the Levetiracetam group).*

FDA Label Image

Levetiracetamtabletsfigure2

This is a data table showing the percentage of patients in a study taking different doses of Levetiracetam and a placebo. The table includes the percentages of patients at different dosage levels ranging from 0% to 45%, as well as the number of patients in each group.*

FDA Label Image

Levetiracetamtabletsfigure3

This information provides the distribution of patients in a study comparing the effects of a placebo (N=104) and Levetiracetam at a dosage of 3000 mg/day (N=180). The percentages represent the number of patients falling within each category, indicating the proportion out of the total number of patients in each group.*

FDA Label Image

Levetiracetamtabletsfigure4

This is statistical data showing the percentage of patients in different categories under two groups: Placebo (N=97) and Levetiracetam (N=101). The data shows the distribution of patients in each group based on the given percentages.*

FDA Label Image

Levetiracetamtabletsfigure5

This text provides data on the percentage of patients in a study comparing the effects of Placebo (N=51) and Levetiracetam (N=58) treatments. The table shows the distribution of patients in different percentage ranges, with the specific percentages ranging from 0% to 45%.*

FDA Label Image

Levetiracetamtabletsfigure6

This is a table showing the percentage of patients in two different groups: Placebo (N=84) and Levetiracetam (N=79). The data includes percentages ranging from 0% to 100%, with specific values at 45.2% and 72.2% for the Placebo and Levetiracetam groups respectively.*

FDA Label Image

Levetiracetamtabletsstructure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.